EA200702027A1 - Дерматологические композиции и соли для лечения дерматологических заболеваний - Google Patents

Дерматологические композиции и соли для лечения дерматологических заболеваний

Info

Publication number
EA200702027A1
EA200702027A1 EA200702027A EA200702027A EA200702027A1 EA 200702027 A1 EA200702027 A1 EA 200702027A1 EA 200702027 A EA200702027 A EA 200702027A EA 200702027 A EA200702027 A EA 200702027A EA 200702027 A1 EA200702027 A1 EA 200702027A1
Authority
EA
Eurasian Patent Office
Prior art keywords
dermatological
treatment
salts
compositions
diseases
Prior art date
Application number
EA200702027A
Other languages
English (en)
Inventor
Мортен Слот Вэйднер
Original Assignee
Астион Фарма А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астион Фарма А/С filed Critical Астион Фарма А/С
Publication of EA200702027A1 publication Critical patent/EA200702027A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к дерматологическим композициям оксапрозина или близкородственного соединения соответственно адаптированного для лечения дерматологического заболевания, где по крайней мере два фермента выбраны из протеин тирозин киназы Syk, протеин тирозин киназы ZAP- 70 и фосфодиэстеразы IV, играют роль в опосредовании дерматологического заболевания. Изобретение также включает дерматологическую композицию для лечения зуда.
EA200702027A 2005-03-30 2006-03-30 Дерматологические композиции и соли для лечения дерматологических заболеваний EA200702027A1 (ru)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DKPA200500437 2005-03-30
DKPA200500438 2005-03-30
US69477405P 2005-06-27 2005-06-27
DKPA200500949 2005-06-27
DKPA200500948 2005-06-27
US69504005P 2005-06-28 2005-06-28
PCT/DK2006/000181 WO2006102900A1 (en) 2005-03-30 2006-03-30 Dermatological compositions and salts for the treatment of dermatological diseases

Publications (1)

Publication Number Publication Date
EA200702027A1 true EA200702027A1 (ru) 2008-02-28

Family

ID=36215671

Family Applications (3)

Application Number Title Priority Date Filing Date
EA200702027A EA200702027A1 (ru) 2005-03-30 2006-03-30 Дерматологические композиции и соли для лечения дерматологических заболеваний
EA200702023A EA200702023A1 (ru) 2005-03-30 2006-03-30 Лечение экзем
EA200702026A EA200702026A1 (ru) 2005-03-30 2006-03-30 Лечение или предупреждение зуда

Family Applications After (2)

Application Number Title Priority Date Filing Date
EA200702023A EA200702023A1 (ru) 2005-03-30 2006-03-30 Лечение экзем
EA200702026A EA200702026A1 (ru) 2005-03-30 2006-03-30 Лечение или предупреждение зуда

Country Status (12)

Country Link
EP (3) EP1707199A1 (ru)
JP (3) JP2008534528A (ru)
KR (3) KR20080005525A (ru)
AU (3) AU2006228869A1 (ru)
BR (3) BRPI0609535A2 (ru)
CA (3) CA2603297A1 (ru)
EA (3) EA200702027A1 (ru)
EC (3) ECSP077843A (ru)
IL (3) IL186022A0 (ru)
MX (3) MX2007012052A (ru)
NO (3) NO20075199L (ru)
WO (3) WO2006102899A2 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0821537D0 (en) * 2008-11-25 2008-12-31 Union Life Sciences Ltd Therapeutic target
US20190046481A1 (en) * 2015-09-18 2019-02-14 Delivra Inc. Transdermal formulations for delivery of propionic and acetic acid nsaids, and their use in the treatment of nsaid-responsive diseases and conditions
WO2018031529A1 (en) * 2016-08-08 2018-02-15 Avedro, Inc. Systems and methods for cross-linking treatments of an eye
EP3532049A1 (en) 2016-10-25 2019-09-04 Ticure Ltd. Fabp4 as a therapeutic target in skin diseases
KR20200097297A (ko) * 2017-12-07 2020-08-18 더마반트 사이언시즈 게엠베하 Pde-4 억제제의 국소 연고 제형 및 피부 병태 치료에서의 이의 용도
RU2685436C1 (ru) * 2018-06-22 2019-04-18 ЗАО "ФармФирма "Сотекс" Трансдермальный препарат для лечения и профилактики болезней суставов и мягких тканей
JP7514598B2 (ja) * 2018-12-20 2024-07-11 小林製薬株式会社 皮膚外用組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE32084B1 (en) * 1967-06-07 1973-04-04 Wyeth John & Brother Ltd Thiazole derivatives
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
IE52909B1 (en) * 1981-04-28 1988-04-13 Wyeth John & Brother Ltd Oxazole derivatives
US4659728A (en) 1985-02-25 1987-04-21 American Home Products Corporation Hydroxy substituted 4,5-diphenyl-2-oxazole propanoic acid
EP0270316A3 (en) * 1986-12-04 1989-12-06 Pfizer Inc. Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
US6090834A (en) * 1993-05-21 2000-07-18 G.D. Searle & Co. Substituted oxazoles for the treatment of inflammation
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
SK48896A3 (en) 1993-10-20 1997-03-05 Boots Co Plc Application of ibuprofen and flurbiprofen as anti-pruritic agents and and pharmaceutical compositions for this use
JPH07316075A (ja) 1994-05-26 1995-12-05 Pola Chem Ind Inc 皮膚外用剤
GB9606429D0 (en) 1996-03-27 1996-06-05 Boots Co Plc Pharmaceutical compositions
DE69733752T2 (de) * 1996-05-20 2006-06-01 G.D. Searle Llc, Chicago Arzneimittel enthaltend oxaprozin-natriumsalz,-kaliumsalz, oder-tris(hydroxymethyl)aminomethansalz
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
WO2005009342A2 (en) 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US20050232957A1 (en) 2004-04-14 2005-10-20 Katz Kenneth A Compositions and methods for moisturizing skin

Also Published As

Publication number Publication date
WO2006102898A2 (en) 2006-10-05
CA2605121A1 (en) 2006-10-05
ECSP077843A (es) 2008-02-20
EP1707201A1 (en) 2006-10-04
CA2603300A1 (en) 2006-10-05
KR20080011280A (ko) 2008-02-01
WO2006102898A3 (en) 2006-12-28
AU2006228869A1 (en) 2006-10-05
WO2006102899A3 (en) 2006-12-28
EP1707199A1 (en) 2006-10-04
NO20075199L (no) 2008-01-02
CA2603297A1 (en) 2006-10-05
IL186022A0 (en) 2008-02-09
WO2006102899A2 (en) 2006-10-05
KR20080005526A (ko) 2008-01-14
AU2006228871A1 (en) 2006-10-05
AU2006228870A1 (en) 2006-10-05
EA200702023A1 (ru) 2008-04-28
MX2007012051A (es) 2008-02-22
NO20075227L (no) 2007-12-09
IL186020A0 (en) 2008-01-20
WO2006102900A1 (en) 2006-10-05
ECSP077845A (es) 2008-02-20
MX2007012052A (es) 2008-02-22
JP2008534526A (ja) 2008-08-28
IL186021A0 (en) 2008-02-09
ECSP077846A (es) 2008-02-20
NO20075218L (no) 2007-12-27
EA200702026A1 (ru) 2008-04-28
JP2008534528A (ja) 2008-08-28
KR20080005525A (ko) 2008-01-14
BRPI0607648A2 (pt) 2009-09-22
EP1707200A1 (en) 2006-10-04
BRPI0609653A2 (pt) 2010-04-20
MX2007012050A (es) 2008-03-11
BRPI0609535A2 (pt) 2010-04-13
JP2008534527A (ja) 2008-08-28

Similar Documents

Publication Publication Date Title
EA200970575A1 (ru) Соединения на основе 4-фенил-6-(2,2,2-трифтор-1-фенилэтокси)пиримидина и способы их применения
ATE528302T1 (de) 3,5-disubstituierte pyrid-2-one, die als hemmer der tec-familie von nicht-rezeptor tyrosin- kinasen nützlich sind
ATE548363T1 (de) 3,5-disubstituierte pyrid-2-one, die sich als inhibitoren der tec-familie von nicht-rezeptor- tyrosinkinasen eignen
MA31090B1 (fr) Derives de dihydropyridine utiles en tant qu'inhibiteurs de la proteine kinase
EA200900152A1 (ru) Ингибиторы пирролотриазинкиназы
EA201000552A1 (ru) Производные пирроло[2,3-d]пиримидина в качестве ингибиторов протеинкиназы в
ATE554087T1 (de) Neue kinaseinhibitoren
EA200702027A1 (ru) Дерматологические композиции и соли для лечения дерматологических заболеваний
ATE451363T1 (de) 3-(indazol-5-yl)-(1,2,4)triazinderivate und verwandte verbindungen als proteinkinaseinhibitoren zur behandlung von krebs
MEP3808A (xx) Derivati pirimidinil aril uree kao fgf inhibitori
EP1841426A4 (en) TERTIARY CARBINAMINES INCLUDING SUBSTITUTED HETEROCYCLES AS BETA SECRETASE INHIBITORS AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE
ATE474835T1 (de) Als inhibitoren von proteinkinasen geeignete aminopyrimidine
SG166827A1 (en) Aminopyrimidines useful as kinase inhibitors
DE602006004844D1 (de) Pyrrolopyrimidine verwendbar als protein kinase inhibitoren
NO20070656L (no) 2,4,6-Trisubstituerte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse ved behandling av kreft
WO2009006389A3 (en) Pyrimidine derivatives useful as raf kinase inhibitors
TW200714604A (en) Substituted heterocycles and the uses thereof
MA31336B1 (fr) Inhibiteurs de pi3k alpha a base de pyridopyrimidinone
TW200716612A (en) Pyrimidine compounds
TW200728305A (en) Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
NO20070655L (no) 2,4,6-Trisubstituerte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse ved behandling av kreft
EA200701930A1 (ru) Производные пиримидина для лечения гиперпролиферативных нарушений
NO20070681L (no) 2, 4, 6-Trisubstituterte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse i behandling av kreft
ATE542814T1 (de) Pyrazinkinaseinhibitoren
MX2009004623A (es) Imidazopiridazinas como inhibidores de la lipido cinasa pi3k.